|
|
|
Volumn 20, Issue 3, 2007, Pages 191-196
|
|
Society for Medicines Research: 40th Anniversary Symposium
a,d
a
Pharmidex
*
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
AVOTERMIN;
BEVACIZUMAB;
CCT 018159;
CISPLATIN;
DIARYL PYRAZOLE;
FROVATRIPTAN;
GEMCITABINE;
JUVISTA;
PEGAPTANIB;
PYRAZOLE DERIVATIVE;
RANIBIZUMAB;
RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3;
ROSCOVITINE;
RSV 604;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
BIOTECHNOLOGY;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DIABETIC RETINOPATHY;
DRUG HALF LIFE;
DRUG STRUCTURE;
EUROPE;
HUMAN;
LIVER CELL CARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MELANOMA;
MENSTRUAL MIGRAINE;
NASOPHARYNX CANCER;
NONHUMAN;
RANDOMIZED CONTROLLED TRIAL;
RETINA MACULA AGE RELATED DEGENERATION;
UNITED KINGDOM;
VIRUS INFECTION;
WOUND;
WOUND HEALING;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTIVIRAL AGENTS;
AWARDS AND PRIZES;
BIOMEDICAL RESEARCH;
CENTRAL NERVOUS SYSTEM AGENTS;
CENTRAL NERVOUS SYSTEM DISEASES;
EUROPE;
HUMANS;
NEOPLASMS;
PHARMACEUTICAL PREPARATIONS;
VIRUS DISEASES;
WOUND HEALING;
|
|
EID: 34250374826
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (3)
|
